The gap between what women experience and what doctors classify
You're 42. Your periods are still regular, arriving every 28 days like clockwork. But for the past year you've been waking up at 3am drenched in sweat. Your periods are heavier than they used to be. You've had two anxiety spirals you've never experienced before. Your mood is unpredictable in the week before your period in a way it simply wasn't in your 30s.
You mention this to your OB-GYN. They check your FSH. It's normal. Your periods are regular. You're told it's probably stress. You're sent home with no diagnosis, no explanation, and no treatment options โ because under current diagnostic criteria, you don't technically qualify as perimenopausal.
Why FSH testing alone is the wrong tool
Here's where the standard medical workup fails: FSH (follicle-stimulating hormone) is the go-to blood test for menopause. But in perimenopause, FSH fluctuates wildly. A single measurement can appear normal even as a woman is experiencing clear hormonal transition. The 2026 international study found women with elevated FSH on one draw and normal FSH a month later โ yet consistent vasomotor and mood symptoms throughout.
The surprise in the research is this: symptoms are often a more reliable indicator of perimenopause stage than a single FSH value. Women with regular cycles, flow changes, and vasomotor symptoms showed hormonal patterns consistent with early perimenopause across multiple physiological measures โ even when their FSH was "normal" on a standard panel.
SFI Health (2026): The international perimenopause study involving 17,000+ women across 158 countries found significant disconnects between the symptoms women recognise as perimenopausal and their clinical classification. Experts are now advocating for a hybrid diagnostic model incorporating symptom-based indicators alongside menstrual criteria โ a shift that would reclassify a meaningful proportion of currently "premenopausal" women in their late 30s and early 40s.
What a hybrid diagnostic model would mean for you
The proposed hybrid approach would classify perimenopause using three convergent criteria: menstrual cycle changes (the current standard), vasomotor and neurological symptoms, and hormonal trajectory over time rather than a single FSH snapshot. A woman with two of three criteria would qualify for support, even if her cycles remain regular.
This is genuinely good news for the women who've been dismissed. It means the conversation with your doctor can include your symptoms as primary data, not as anecdotal noise alongside a "normal" blood result. It also means HRT โ which is currently withheld from women until they're formally classified as perimenopausal โ becomes a conversation that can start earlier for the women who need it.
- Document your symptoms with dates: night sweats, mood shifts, cycle flow changes, sleep disruption, joint pain. This pattern data is now recognized as diagnostically meaningful.
- Ask for serial FSH testing (two measurements taken weeks apart) rather than a single draw โ a single normal result does not rule out perimenopause.
- Reference the 2026 international study if you're being dismissed. The science now formally supports symptom-based criteria alongside cycle data.
- Ask specifically about a menopause specialist or a clinic with updated diagnostic protocols โ not every OB-GYN practice has incorporated the new evidence yet.
Perimenopause diagnosis is evolving. If you're in your late 30s or 40s with symptoms that feel hormonal and you're being told everything is normal, it's appropriate to seek a second opinion from a menopause specialist. The Menopause Society maintains a directory of certified practitioners at menopause.org.
- SFI Health (2026). Perimenopause in 2026: why new global research calls for updated diagnostic criteria. https://sfihealth.com/news/perimenopause-in-2026
- STAT News (2026). The truth about perimenopause and middle age. https://www.statnews.com/2026/03/26/perimenopause-symptoms-evidence-supplements/
- Harlow SD et al. (2012). STRAW+10: addressing the unfinished agenda of staging reproductive aging. Menopause, 19(4):387-395.
- Ms. Magazine (2026). Symptoms, Hormones and the Fight for Better Care. https://msmagazine.com/2026/04/07/symptoms-hormones-woman-health-menopause-perimenopause-treatment/
- NIH Office of Disease Prevention (2026). Advancing Research to Improve Health During the Menopausal Transition.